Loading
 Siriporn Proungvitaya

Siriporn Proungvitaya

School of Medical Technology,
Faculty of Associated Medical Sciences,
Khon Kaen University
7801638413: H-INDEX 8
Education Level
  • ปริญญาตรี ()
  • ปริญญาเอก ()
  • ปริญญาเอก ()
Expert
  • Clinical proteomics (โปรติโอมิคส์คลินิก)
  • Clinical chemistry (เคมีคลินิค)
  • Tumor genetics and biology (มะเร็ง)

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma Wongkham, S.
Boonla, C.
Patrakitkomjorn, S.
Howard, M.
Sripa, B.
Wongkham, C.
Bhudhisawasdi, V.
2003
2. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin Feng, L.
Patrakitkomjorn, S.
Saya, H.
2004
3. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway Feng, L.
Patrakitkomjorn, S.
Saya, H.
2005
4. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 Patrakitkomjorn, S.
Kobayashi, D.
Wilson, M.M.
Saya, H.
2008
5. A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma Kamlua, S.
Patrakitkomjorn, S.
Jearanaikoon, P.
Menheniott, T.R.
Giraud, A.S.
Limpaiboon, T.
2012
6. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. Montira Janan
Siriporn Proungvitaya
Temduang Limpaiboon
Tanakorn Proungvitaya
Sittiruk Roytrakul
Chaisiri Wongkham
Patcharee Jearanaikoon
Siri Chur-in
Sopit Wongkham
2012
7. Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma Tolek, A
Wongkham, C
Proungvitaya, S
Silsirivanit, A
Roytrakul, S
Khuntikeo, N
Wongkham, S
2012
8. Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma Nutthasirikul, N.
Limpaiboon, T.
Leelayuwat, C.
Patrakitkomjorn, S.
Jearanaikoon, P.
2013
9. DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma T. Limpaiboon
R. Amornpisutt
S. Proungvitaya
P. Jearanaikoon
2014
10. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. Ammala Monsouvanh
Tanakorn Proungvitaya
Temduang Limpaiboon
Chaisiri Wongkham
Sopit Wongkham
Vor Luvira
Siriporn Proungvitaya
2014
11. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Rattaya Amornpisutt
Siriporn Proungvitaya
Patcharee Jearanaikoon
Temduang Limpaiboon
2015
12. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. Sombattheera, S
Proungvitaya, T
Limpaiboon, T
Wongkham, S
Wongkham, C
Luvira, V
Proungvitaya, S
2015
13. Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma Temduang Limpaiboon
Chaiyachet Nanok
Siriporn Proungvitaya
Patcharee Jearanaikoon
Ake Pugkhem
Anucha Puapairoj
2016
14. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016
15. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. Patrakitkomjorn, S.
Sombattheera, S.
Boonsiri, P.
Limpaiboon, T.
Wongkham, C.
Titapun, A.
Proungvitaya, T.
2017
16. High expression of CCDC25 in cholangiocarcinoma tissue samples Proungvitaya, S
Klinthong, W
Proungvitaya, T
Limpaiboon, T
Jearanaikoon, P
Roytrakul, S
Wongkham, C
Nimboriboonporn, A
Wongkham, S
2017
17. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for Cholangiocarcinoma Chaiyachet Nanok
Patcharee Jearanaikoon
Siriporn Proungvitaya
Temduang Limpaiboon
2018
18. High levels of APEX1 in sera from patients with cholangiocarcinoma Tanakorn Proungvitaya
Siriporn Proungvitaya
Doungdean Tummanatsakun
Sittiruk Roytrakul
2018
19. Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma Chaiyachet Nanok
Chanvit Leelayuwat
Patcharee Jearanaikoon
Siriporn Proungvitaya
Temduang Limpaiboon
2018
20. Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma Siriporn Proungvitaya
Tanakorn Proungvitaya
Surangkana Sanmai
Sittiruk Roytrakul
2018
21. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. Settasatian, C.
Patrakitkomjorn, S.
Limpaiboon, T.
2019
22. Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma Doungdean Tummanatsakun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Temduang Limpaiboon
Sopit Wongkham
Chaisiri Wongkham
Atit Silsirivanit
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019
23. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases Wasenang, W
Chaiyarit, P
Proungvitaya, S
Limpaiboon, T
2019
24. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Sanmai, S
Proungvitaya, T
Limpaiboon, T
Chua-On, D
Seubwai, W
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sangkhamanon, S
Proungvitaya, S
2019
25. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. Patrakitkomjorn, S.
Jearanaikoon, P.
Limpaiboon, T.
2019
26. Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior Srijampa, S
Buddhisa, S
Ngernpimai, S
Leelayuwat, C
Proungvitaya, S
Chompoosor, A
Tippayawat, P
2020
27. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Jusakul, A.
Titapun, A.
Patrakitkomjorn, S.
2020
Count 17 15 19 0

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma Wongkham, S.
Boonla, C.
Patrakitkomjorn, S.
Howard, M.
Sripa, B.
Wongkham, C.
Bhudhisawasdi, V.
2003 Cancer Letters
1 (195), pp. 93-99
2. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin Feng, L.
Patrakitkomjorn, S.
Saya, H.
2004 FEBS Letters
1-3 (557), pp. 275-282
3. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway Feng, L.
Patrakitkomjorn, S.
Saya, H.
2005 Journal of Biological Chemistry
47 (280), pp. 39524-39533
4. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 Patrakitkomjorn, S.
Kobayashi, D.
Wilson, M.M.
Saya, H.
2008 Journal of Biological Chemistry
14 (283), pp. 9399-9413
5. A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma Kamlua, S.
Patrakitkomjorn, S.
Jearanaikoon, P.
Menheniott, T.R.
Giraud, A.S.
Limpaiboon, T.
2012 Oncology Reports
4 (27), pp. 1207-1212
6. Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma Nutthasirikul, N.
Limpaiboon, T.
Leelayuwat, C.
Patrakitkomjorn, S.
Jearanaikoon, P.
2013 International Journal of Oncology
4 (42), pp. 1181-1188
7. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Proungvitaya, T.
Techasen, A.
Limpaiboon, T.
Wongkham, S.
Wongkham, C.
Somintara, O.
Patrakitkomjorn, S.
2016 Tumor Biology
(), pp. 1-9
8. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma Patrakitkomjorn, S.
Sombattheera, S.
Boonsiri, P.
Limpaiboon, T.
Wongkham, C.
Titapun, A.
Proungvitaya, T.
2017 Oncology Letters
4 (14), pp. 4943-4948
9. High expression of CCDC25 in cholangiocarcinoma tissue samples Patrakitkomjorn, S.
Proungvitaya, T.
Limpaiboon, T.
Jearanaikoon, P.
Wongkham, C.
2017 Oncology Letters
2 (14), pp. 2566-2572
10. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for Cholangiocarcinoma Nanok, C.
Jearanaikoon, P.
Patrakitkomjorn, S.
Limpaiboon, T.
2018 Molecular Medicine Reports
3 (17), pp. 4145-4153
11. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma Settasatian, C.
Patrakitkomjorn, S.
Limpaiboon, T.
2019 Pathology Research and Practice
7 (215), pp.
12. Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Wongkham, S.
Wongkham, C.
Silsirivanit, A.
Somintara, O.
Patrakitkomjorn, S.
2019 Biomolecules
9 (9), pp.
13. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases Chaiyarit, P.
Patrakitkomjorn, S.
Limpaiboon, T.
2019 Clinical Epigenetics
1 (11), pp.
14. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Seubwai, W.
Wongkham, S.
Wongkham, C.
Somintara, O.
Patrakitkomjorn, S.
2019 Oncology Letters
6 (17), pp. 5275-5282
15. The upregulation of OCT4 in acidic extracellular pH is associated with gemcitabine resistance in cholangiocarcinoma cell lines Patrakitkomjorn, S.
Jearanaikoon, P.
Limpaiboon, T.
2019 Asian Pacific Journal of Cancer Prevention
9 (20), pp. 2745-2748
16. Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior Buddhisa, S.
Ngernpimai, S.
Leelayuwat, C.
Patrakitkomjorn, S.
Chompoosor, A.
Tippayawat, P.
2020 Bioconjugate Chemistry
(), pp.
17. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Jusakul, A.
Titapun, A.
Patrakitkomjorn, S.
2020 Oncology Letters
1 (19), pp. 930-942

Title Authors Year Journal title
1. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. Tolek, A
Wongkham, C
Proungvitaya, S
Silsirivanit, A
Roytrakul, S
Khuntikeo, N
Wongkham, S
2012 Experimental biology and medicine (Maywood, N.J.)
10 (237), pp. 1142-9
2. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. Janan, M
Proungvitaya, S
Limpaiboon, T
Proungvitaya, T
Roytrakul, S
Wongkham, C
Jearanaikoon, P
Chur-in, S
Wongkham, S
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 107-14
3. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. Monsouvanh, A
Proungvitaya, T
Limpaiboon, T
Wongkham, C
Wongkham, S
Luvira, V
Proungvitaya, S
2014 Asian Pacific journal of cancer prevention : APJCP
21 (15), pp. 9511-5
4. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. Sombattheera, S
Proungvitaya, T
Limpaiboon, T
Wongkham, S
Wongkham, C
Luvira, V
Proungvitaya, S
2015 Asian Pacific journal of cancer prevention : APJCP
4 (16), pp. 1367-70
5. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Amornpisutt, R
Proungvitaya, S
Jearanaikoon, P
Limpaiboon, T
2015 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
7 (36), pp. 4973-8
6. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (37), pp. 13659-13667
7. High expression of CCDC25 in cholangiocarcinoma tissue samples. Proungvitaya, S
Klinthong, W
Proungvitaya, T
Limpaiboon, T
Jearanaikoon, P
Roytrakul, S
Wongkham, C
Nimboriboonporn, A
Wongkham, S
2017 Oncology letters
2 (14), pp. 2566-2572
8. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. Proungvitaya, S
Sombattheera, S
Boonsiri, P
Limpaiboon, T
Wongkham, S
Wongkham, C
Titapun, A
Proungvitaya, T
2017 Oncology letters
4 (14), pp. 4943-4948
9. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. Nanok, C
Jearanaikoon, P
Proungvitaya, S
Limpaiboon, T
2018 Molecular medicine reports
3 (17), pp. 4145-4153
10. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. Wasenang, W
Chaiyarit, P
Proungvitaya, S
Limpaiboon, T
2019 Clinical epigenetics
1 (11), pp. 39
11. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. Wasenang, W
Puapairoj, A
Settasatian, C
Proungvitaya, S
Limpaiboon, T
2019 Pathology, research and practice
(), pp. 152451
12. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. Sanmai, S
Proungvitaya, T
Limpaiboon, T
Chua-On, D
Seubwai, W
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sangkhamanon, S
Proungvitaya, S
2019 Oncology letters
6 (17), pp. 5275-5282
13. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. Choodetwattana, P
Proungvitaya, S
Jearanaikoon, P
Limpaiboon, T
2019 Asian Pacific journal of cancer prevention : APJCP
9 (20), pp. 2745-2748
14. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. Chanakankun, R
Proungvitaya, T
Chua-On, D
Limpaiboon, T
Roytrakul, S
Jusakul, A
Titapun, A
Jarearnrat, A
Proungvitaya, S
2020 Oncology letters
1 (19), pp. 930-942
15. Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior. Srijampa, S
Buddhisa, S
Ngernpimai, S
Leelayuwat, C
Proungvitaya, S
Chompoosor, A
Tippayawat, P
2020 Bioconjugate chemistry
4 (31), pp. 1133-1143

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Serum Adhesion Molecule-1 (ICAM-1) as a Potential Prognostic Marker for Cholangiocarcinoma Patients Montira Janan
Siriporn Proungvitaya
Temduang Limpaiboon
Tanakorn Proungvitaya
Sittiruk Roytrakul
Chaisiri Wongkham
Patcharee Jearanaikoon
Siri Chur-in
Sopit Wongkham
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 107.0-114.0
7 0 0 0 0 0 7
2. Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma Arthit Tolek
Chaisiri Wongkham
Siriporn Proungvitaya
Atit Silsirivanit
Sittiruk Roytrakul
Narong Khuntikeo
Sopit Wongkham
2012 EXPERIMENTAL BIOLOGY AND MEDICINE
10.0 (237.0), pp. 1142.0-1149.0
20 0 0 0 0 0 20
3. DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma T. Limpaiboon
R. Amornpisutt
S. Proungvitaya
P. Jearanaikoon
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S98-S98
0 0 0 0 0 0 0
4. Serum Cathepsin B to Cystatin C Ratio as a Potential Marker for the Diagnosis of Cholangiocarcinoma Ammala Monsouvanh
Tanakorn Proungvitaya
Temduang Limpaiboon
Chaisiri Wongkham
Sopit Wongkham
Vor Luvira
Siriporn Proungvitaya
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
21.0 (15.0), pp. 9511.0-9515.0
17 0 0 0 0 0 17
5. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma Rattaya Amornpisutt
Siriporn Proungvitaya
Patcharee Jearanaikoon
Temduang Limpaiboon
2015 TUMOR BIOLOGY
7.0 (36.0), pp. 4973.0-4978.0
24 0 0 0 0 0 24
6. Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma Temduang Limpaiboon
Chaiyachet Nanok
Siriporn Proungvitaya
Patcharee Jearanaikoon
Ake Pugkhem
Anucha Puapairoj
2016 CANCER RESEARCH
(76.0), pp.
0 0 0 0 0 0 0
7. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Daraporn Chua-on
Tanakorn Proungvitaya
Anchalee Techasen
Temduang Limpaiboon
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sungkhamanon
Siriporn Proungvitaya
2016 TUMOR BIOLOGY
10.0 (37.0), pp. 13659.0-13667.0
17 0 0 0 0 0 17
8. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma Siriporn Proungvitaya
Sutthikan Sombattheera
Patcharee Boonsiri
Temduang Limpaiboon
Sopit Wongkham
Chaisiri Wongkham
Attapol Titapun
Tanakorn Proungvitaya
2017 ONCOLOGY LETTERS
4.0 (14.0), pp. 4943.0-4948.0
6 0 0 0 0 0 6
9. High expression of CCDC25 in cholangiocarcinoma tissue samples Siriporn Proungvitaya
Wachiraya Klinthong
Tanakorn Proungvitaya
Temduang Limpaiboon
Patcharee Jearanaikoon
Sittiruk Roytrakul
Chaisiri Wongkham
Anongporn Nimboriboonporn
Sopit Wongkham
2017 ONCOLOGY LETTERS
2.0 (14.0), pp. 2566.0-2572.0
1 0 0 0 0 0 1
10. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma Chaiyachet Nanok
Patcharee Jearanaikoon
Siriporn Proungvitaya
Temduang Limpaiboon
2018 MOLECULAR MEDICINE REPORTS
3.0 (17.0), pp. 4145.0-4153.0
1 0 0 0 0 0 1
11. High levels of APEX1 in sera from patients with cholangiocarcinoma Tanakorn Proungvitaya
Siriporn Proungvitaya
Doungdean Tummanatsakun
Sittiruk Roytrakul
2018 CANCER SCIENCE
(109.0), pp. 955.0-955.0
0 0 0 0 0 0 0
12. Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma Chaiyachet Nanok
Chanvit Leelayuwat
Patcharee Jearanaikoon
Siriporn Proungvitaya
Temduang Limpaiboon
2018 CANCER SCIENCE
(109.0), pp. 243.0-243.0
0 0 0 0 0 0 0
13. Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma Siriporn Proungvitaya
Tanakorn Proungvitaya
Surangkana Sanmai
Sittiruk Roytrakul
2018 CANCER SCIENCE
(109.0), pp. 955.0-955.0
0 0 0 0 0 0 0
14. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma Wiphawan Wasenang
Anucha Puapairoj
Chatri Settasatian
Siriporn Proungvitaya
Temduang Limpaiboon
2019 PATHOLOGY RESEARCH AND PRACTICE
7.0 (215.0), pp.
0 0 0 0 0 0 0
15. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma Doungdean Tummanatsakun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Temduang Limpaiboon
Sopit Wongkham
Chaisiri Wongkham
Atit Silsirivanit
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019 BIOMOLECULES
9.0 (9.0), pp.
1 0 0 0 0 0 1
16. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases Wiphawan Wasenang
Ponlatham Chaiyarit
Siriporn Proungvitaya
Temduang Limpaiboon
2019 CLINICAL EPIGENETICS
(11.0), pp.
14 0 0 0 0 0 14
17. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Surangkana Sanmai
Tanakorn Proungvitaya
Temduang Limpaiboon
Daraporn Chua-On
Wunchana Seubwai
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019 ONCOLOGY LETTERS
6.0 (17.0), pp. 5275.0-5282.0
2 0 0 0 0 0 2
18. Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior Sukanya Srijampa
Surachat Buddhisa
Sawinee Ngernpimai
Chanvit Leelayuwat
Siriporn Proungvitaya
Apiwat Chompoosor
Patcharaporn Tippayawat
2020 BIOCONJUGATE CHEMISTRY
4.0 (31.0), pp. 1133.0-1143.0
0 0 0 0 0 0 0
19. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Ravinnipa Chanakankun
Tanakorn Proungvitaya
Daraporn Chua-On
Temduang Limpaiboon
Sittiruk Roytrakul
Apinya Jusakul
Attapol Titapun
Apiwat Jarearnrat
Siriporn Proungvitaya
2020 ONCOLOGY LETTERS
1.0 (19.0), pp. 930.0-942.0
0 0 0 0 0 0 0

Title Authors Year Journal title

Title Authors NRIIS type Year NRIIS Scholarship

0.06747698783874512